Pictet Asset Management (Switzerland)’s Antares Pharma, Inc. ATRS Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,300	Closed	-$46K	–	1723
2022 Q1	$46K	Hold	11,300	–	–	﹤0.01%	1661
2021 Q4	$40K	Hold	11,300	–	–	﹤0.01%	1706
2021 Q3	$41K	Buy	+11,300	New	+$45.7K	﹤0.01%	1733

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ATRS Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 11,300 shares — an estimated $46K sold.

Pictet Asset Management (Switzerland) first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $46K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Pictet Asset Management (Switzerland) reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 11,300 Antares Pharma, Inc. shares in Q2 2022, an estimated $46K.
Pictet Asset Management (Switzerland) first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Pictet Asset Management (Switzerland)'s Antares Pharma, Inc. position peaked at $46K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.